Skip to Content

Your Location Within Site:


Pharmaceuticals and biotechnology

IRL has specialist chemical and biochemical expertise for the discovery of new drug candidates to target a range of conditions and diseases, as well as dedicated bioprocessing expertise for the necessary assessment of new drug candidates. We have also recently developed capability in making renewable polymers for use in paint and other industrial products. 

Glass image

Some of the cutting edge research programmes our world class Carbohydrate Chemistry group is actively engaged in include:

Renewable polymers

IRL has developed capability in making renewable polymers for use in paint and other industrial products, using natural materials. Read more >>

Glycotherapeutics

We are a world leader in the niche area of glycotherapeutics, discovering new drug treatments from carbohydrate materials. Read more >>

Gut health and immune development

We are applying our expertise in the structural analysis of complex carbohydrates to better understand the role of beneficial bacteria in human gut health. Read more >>

Carbohydrate nanotechnology

This programme will isolate, synthesise, formulate and test new carbohydrate-containing chemical entities to identify potential adjuvant candidates for the development of novel, more effective, cell-mediated vaccines. Read more >>

Chiral scaffolds

We have developed world-leading expertise in ‘iminosugar’ chemistry through our highly successful programme of drug discovery. This expertise has now been directed towards building a library of novel chiral scaffolds for the pharmaceutical industry. Read more >>

New synthesis methodologies

We are researching ways of synthesising compounds known as sulphated oligosaccharides that play an important role in biological systems.  Read more >>